Loading…
Reported covered position: Senator John Warner (Legislative Counsel, Legislative Assistant, Legislative Correspondent, Staff Assistant)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2026 · third_quarter · Q3
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Source: Senate LDA
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Fair Allocation of Interstate Rates Act
Client: DH DIAGNOSTICS, LLC · Firm: DH DIAGNOSTICS LLC
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Fair Allocation of Interstate Rates Act
Client: DH DIAGNOSTICS, LLC · Firm: DH DIAGNOSTICS LLC
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Fair Allocation of Interstate Rates Act
Client: DH DIAGNOSTICS, LLC · Firm: DH DIAGNOSTICS LLC
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
Issues related to diagnostic testing, Alzheimer's, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
Issues related to diagnostic testing, Alzheimer's, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2026 · second_quarter · Q2
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Funding for diagnostics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2026 · first_quarter · Q1
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025
Funding for diagnostics
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2025 · fourth_quarter · Q4
Issues related to diagnostic testing, Oncology, Hepatitis C funding Discussions reading the Rural Health Transformation funding
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
Issues related to tariffs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2025 · third_quarter · Q3
Issues related to diagnostic testing, Alzheimer's, Oncology, Hepatitis C funding
Issues related to diagnostic testing, Alzheimer's, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269).
issues related to tariffs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2025 · second_quarter · Q2
Issues related to diagnostic testing, Alzheimer's, Oncology, Hepatitis C funding
Issues related to diagnostic testing, Alzheimer's, Oncology and Hepatitis C
Issues related to tariffs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2025 · first_quarter · Q1
Issues related to diagnostic testing, Alzheimer's, Oncology, Hepatitis C funding
Issues related to diagnostic testing, Alzheimer's, Oncology and Hepatitis C
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2024 · fourth_quarter · Q4
Issues related to diagnostic testing, Antimicrobial Resistance, Hepatitis C funding and pandemic preparedness
Issues related to diagnostic testing, Alzheimer's, Antimicrobial Resistance and Hepatitis C
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2024 · third_quarter · Q3
Issues related to diagnostic testing, Antimicrobial Resistance, Hepatitis C funding and pandemic preparedness
Issues related to diagnostic testing, Antimicrobial Resistance and Hepatitis C
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DH DIAGNOSTICS, LLC via DH DIAGNOSTICS LLC
2024 · third_quarter · RR
issues related to diagnostic testing, antimicrobial resistance, Alzheimer's